Form D · Hedge Fund

BIOREVOLUTION CAPITAL PARTNERS, LP

Providence, RI · CIK 0001419913

Offering snapshot reported Jan 8, 2020 · SEC filing

Reported sold
$805K
Indefinite offering
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 1, 2007
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$403K$805KMar 11, 2009: $665,000.00Mar 11, 2009Feb 22, 2010: $705,000.00Feb 15, 2011: $805,000.00Feb 13, 2012: $805,000.00Feb 13, 2013: $805,000.00Feb 4, 2014: $805,000.00Jan 28, 2015: $805,000.00Jan 28, 2015: $805,000.00Jan 27, 2016: $805,000.00Jan 20, 2017: $805,000.00Jan 12, 2018: $805,000.00Jan 8, 2019: $805,000.00Jan 8, 2020: $805,000.00Jan 8, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 8, 2020Amendment$805,000$0vs Jan 8, 201910SEC filing
Jan 8, 2019Amendment$805,000$0vs Jan 12, 201810SEC filing
Jan 12, 2018Amendment$805,000$0vs Jan 20, 201710SEC filing
Jan 20, 2017Amendment$805,000$0vs Jan 28, 201510SEC filing
Jan 27, 2016Amendment$805,000$0vs Jan 28, 201510SEC filing
Jan 28, 2015Amendment$805,000$0vs Feb 4, 201410SEC filing
Jan 28, 2015Amendment$805,000$0vs Feb 4, 201410SEC filing
Feb 4, 2014Amendment$805,000$0vs Feb 13, 201310SEC filing
Feb 13, 2013Amendment$805,000$0vs Feb 13, 201210SEC filing
Feb 13, 2012Amendment$805,000$0vs Feb 15, 201110SEC filing
Feb 15, 2011Amendment$805,000$100,000vs Feb 22, 201010SEC filing
Feb 22, 2010Amendment$705,000$40,000vs Mar 11, 20099SEC filing
Mar 11, 2009Amendment$665,000No comparisonNot reportedSEC filing
Nov 29, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-111687

Source: Form D, filed Jan 8, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph A. Aguilera Executive
Bio Revolution Capital, Llc Executive
Bio Revolution Capital Management Llc Executive
Noel J. Guillama Executive
Christopher P. Lowe Executive
Don Sellers Executive
Eugene Seymour Executive
Karen Sterling Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
Biorevolution Capital, Llc 94 Arbor Drive
Providence, RI, 02908